BeStock  
Stocks › Biotechnology › AVLN

Avalyn Pharma AVLN

US equityMarket cap rank #3150Biotechnology
$25.53 +$0.10 (+0.39%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $25.53 0.00%
Open$25.30
Prev close$25.43
Day range$25.26 – $26.31
Volume202.9K
Market cap$1.13B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-11.0x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average -13.5x

Price / book2.8x
CheapRich

Above its usual level · 67th percentile, 5-year average -1.8x

#3580 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-18x-12x-5x1xApr '26Jul '26Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$46.66
Price vs. fair value-45.3%Trading below the estimate
Star rating★★★★★
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.84 – -1.77 67% (pricier than usual) #3580 of 5317 (1 = cheapest)
PE -10.96 -8.75 -13.52 95% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★★
Fair value estimate$46.66
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on AVLN.

Leave a comment

Scroll to Top